Article
Measurement of urinary CDH and CTH by tandem mass spectrometry in patients hemizygous and heterozygous for Fabry disease.
Journal of inherited metabolic disease - 1 Jan 2005
Mills K, Morris P, Lee P, Vellodi A, Waldek S, Young E, Winchester B
Abstract excerpt
Fabry disease is an X-linked disorder of glycosphingolipid metabolism resulting from a deficiency of the lysosomal enzyme alpha-galactosidase A. This deficiency leads to the progressive accumulation, in lysosomes of visceral tissues and in body fluids of hemizygotes, of the glycosphingolipids globotriaosylceramide (CTH, Gb(3) or GL-3) and galabiosylceramide (CDH) and to a lesser extent the blood group AB and B...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
